FAQ on CoViD-19- vaccination
Our offer is valid for all employees of the following companies participating in the vaccination campaign (in alphabetical order):
- Adolf Würth GmbH & Co.KG
- AIR LIQUIDE Deutschland GmbH
- ARLANXEO Deutschland GmbH
- Atos Information Technology GmbH
- Ausbildungsinitiative Rheinland
- Baumann Logistik
- Bayer AG
- Bayer AG, Crop Science
- Bayer AG, Pharmaceuticals Division
- Bayer Direct Services GmbH
- Bayer Gastronomie GmbH
- Bayer Intellectual Property GmbH
- Bayer Vital GmbH
- Bertschi Transport GmbH
- Bilfinger OKI Isoliertechnik GmbH
- CHEMION Logistik GmbH
- Computacenter AG & Co. oHG
- consilab Gesellschaft für
- Covestro AG
- Covestro Deutschland AG
- Covestro First Real Estate GmbH
- Covestro GmbH
- Covestro Intellectual Property
- Covestro Procurement Services
- Currenta GmbH & Co. OHG
- Dralon GmbH i.I. 2
- EagleBurgmann Germany GmbH & Co. KG
- Echoes Industrieservice GmbH
- Exyte Central Europe GmbH
- GMA-Werkstoffprüfung GmbH
- Heraeus Deutschland GmbH & Co. KG
- Horst Goetz GmbH & Co.KG-Spezial-
- INEOS Manufacturing Deutschland GmbH
- INEOS Styrolution Köln GmbH
- Ingenieurbüro Grobecker GmbH
- INVITE GmbH
- Job@ctive GmbH
- Kemira Germany GmbH
- Kronos Titan GmbH
- LANXESS AG
- LANXESS Deutschland GmbH
- LANXESS Distribution GmbH
- LANXESS Global Business Services
- Lauer GmbH
- LEVACO CHEMICALS GMBH
- Linde Gas Produktions-
- Momentive Performance
- NKT GmbH & Co.KG
- Nouryon Chemicals GmbH
- Pallas Versicherung
- Pfaudler GmbH
- Polymaterials AG
- pronova BKK
- RWE Generation SE
- Saltigo GmbH
- TALKE-Emmerich GmbH & Co. KG
- TECTRION GmbH
- TravelBoard GmbH
- TÜV Süd Chemie Service GmbH
- Uhlenbruck Energie GmbH & Co. KG
- UL International Germany GmbH
- Venator Uerdingen GmbH
- Weber Industrieller Rohrleitungsbau
- Yncoris GmbH & Co. KG
In principle, yes. However, the quantities of vaccine ordered will probably - as of 05.25. - not be fully supplied at least for the first week of vaccination starting June 8. Unfortunately, the supply of vaccines is still difficult. Therefore, bookable vaccination slots will likely be limited at the outset. The companies themselves decide on the allocation of their respective vaccination quotas. For example, in the CURRENTA Group, all shift employees are served first before others can log on. As soon as enough vaccine is available, the registration will of course be opened for everyone.
Employees who have already made an appointment for vaccination with their family doctor or at a public vaccination center on their own initiative should keep this appointment as scheduled. The reason this is the still non-binding volume allocations for vaccine allocation by the federal government or the state.
Yes. We must coordinate vaccinations so that social distancing rules and hygiene measures can always be safely observed. This only works if the occupancy of the vaccination sites is planned and distributed throughout the day. In addition, it is unlikely that full capacity vaccination will be available initially due to insufficient vaccine supplies, so available vaccination slots will need to be prioritized. The employees who can register next will be informed 1-2 days before each.
- Register for your vaccination at https://chempark.impfsystem.de, by entering your personnel number (see CHEMPARK ID card) in the "Personal ID" field and filling in the fields with your date of birth and address and contact details.
- Choose your preferred date for the first and second vaccination. The online tool automatically offers you only available vaccination times and takes into account the minimum interval between first and second dose.
- You will receive an appointment confirmation with QR code for admission control. Print this out or save it to your smartphone. The QR code must be easily identifiable. It is your ticket to enter the vaccination center on the scheduled date and is scanned at the entrance.
The CHEMPARK vaccination system records whether - and if so, with which vaccine and batch - your vaccination was successfully carried out. Even if your vaccination was canceled or did not take place, this will be noted in the system.
If you are younger than 60: yes. If you are 60 or older: almost certainly as well. With the exception of the most recently approved vaccine from Johnson & Johnson, which - like the preparation from AstraZeneca - only has a recommendation from the Standing Commission on Vaccination for people over 60, all vaccines approved in Europe require two administrations to build up the optimal protective effect in each case.
You can book the appointment for the second vaccination directly with your initial appointment using the tool.
Even after the first vaccination, a good protective effect can already be detected. If you are unable to attend the second vaccination at CHEMPARK, you should arrange to receive your second vaccination at a public vaccination center.
Employees of the CURRENTA Group can be vaccinated during working hours at CURRENTA Health and Safety or at a vaccination center outside CHEMPARK. The extent to which all other companies at the CHEMPARK also allow their employees to be vaccinated during working hours cannot be answered here in general terms. Please clarify this with your supervisor or the HR department.
- Your CHEMPARK ID
- Your personal ID
- Your yellow vaccination card (if available)
- A printout of the QR code you receive when making the appointment; optionally, you can also show the QR code on your smartphone
- Two (2) printouts of the medical history/information sheet completed in advance as far as possible
- Two (2) printouts of the consent form (download form here)
The actual vaccination takes less than 5 minutes. However, please be sure to allow 15 to 30 minutes of observation time after vaccination and a little lead time as well. All in all, vaccination should take a maximum of about 45 minutes from entering to leaving the vaccination center.
Bring all documents already filled out and signed if you have no more questions about the vaccination. If you still have questions and therefore cannot/will not completely fill out or sign the medical history form yet, you will have the opportunity to speak with a physician on site. However, please allow additional waiting time for this.
Please dress in such a way that the upper arm can be cleared easily and quickly.
Yes. You will receive proof in your yellow vaccination card. Please be sure to bring this - if available - with you to the vaccination.
Yes. You will then receive a new vaccination card with proof of COVID-19 vaccination. However, you should always document all vaccinations in an ID card. To do this, it is best to contact your family doctor to have past vaccinations updated.
Health and Safety as part of the COVID 19 vaccination?
No. Although the introduction of a digital vaccination card is planned throughout Europe, it is unlikely to get off the ground quickly enough. Currently, it is still unclear how those who were vaccinated before the app was completed will subsequently receive the digital proof. In any case, the vaccination can be verified with the hard copy yellow vaccination card.
No. There is no choice at CHEMPARK, nor at the public vaccination centers.
At CHEMPARK, it goes without saying that only vaccines approved in the EU that have been tested for efficacy and safety are vaccinated in accordance with the recommendations of the Standing Commission on Vaccination (StiKo). Currently, only the vaccines from BioNTech Pfizer and Moderna can be used without age restriction for the age groups relevant at CHEMPARK. For AstraZeneca, there is a StiKo recommendation only for those over 60 years of age because of the very low risk of blood clot formation. This also applies to the vaccine from Johnson & Johnson, which has been approved since March 9 but is unlikely to be available at CHEMPARK.
The vaccine has been ordered by CURRENTA through a public pharmacy in Leverkusen - this is the legal framework. Vaccinations at the public vaccination centers are not affected by the vaccinations at CHEMPARK, which take place in addition.
The Robert Koch Institute cites efficacy rates of 95% and 94.5% for BioNTech Pfizer and Moderna vaccines, respectively, and around 70% for AstraZeneca. BUT: People vaccinated with AstraZeneca's vaccine are also virtually 100% protected from severe or life-threatening disease, a large-scale study shows *1. It is only the protection against diseases with a mild symptom course that is slightly poorer.
This depends on the type and quantity of vaccines provided by the federal state. If those to be vaccinated are 60 years of age and older, there is nothing to prevent the use of AstraZeneca's preparation. Since most employees are younger than 60, it will come down to a BioNTech Pfizer or Moderna vaccination for them anyway. AstraZeneca's vaccination of volunteers under 60 requires special consideration of individual health conditions and possible predispositions to the very rare complications observed. Those under 60 who are eager to be vaccinated with AstraZeneca should ask their primary care physician. At CHEMPARK, the AstraZeneca vaccination is not provided for younger people.
It is not yet clear which vaccines will be made available to CHEMPARK and in what quantities. It is not unlikely that only one of the vaccines recommended without age restriction will be used. Nevertheless, no one who has the chance to be vaccinated now should forgo immunization in order to wait for vaccination with their vaccine of choice. All vaccines licensed in the EU provide virtually complete protection against severe or life-threatening disease. It is not advisable to wait until vaccine availability allows a choice without any protection against severe and life-threatening COVID-19 infection.
However, it is of course up to each person to have a vaccination carried out at a later date in public vaccination centers. However, this does not mean that there will/can be a choice in vaccine.
With all vaccinations, slight pain at the injection site can be expected for a few days immediately after vaccination. Vaccine reactions such as fatigue, headache, and a general feeling of illness are likely, but do not occur in everyone. A slightly elevated body temperature may also occur, but true fever (well above 38° C body temperature) is rare. Important: The reactions described are not cause for alarm, but rather show that the body's immune system is reacting to the vaccine and building up defenses.
No. It continues to apply: Anyone with a fever or who feels ill - whatever the suspected cause - is not allowed in the CHEMPARK.
Anyone who is acutely ill, for example with an influenza infection, is not allowed in the CHEMPARK and should also not be vaccinated.
No! All measures of the Corona Protection Concept continue to apply to vaccinated individuals as well: Distance and hygiene rules, mask wearing, ventilation requirements. Background: It is not yet clear to what extent vaccinated persons can still temporarily carry the pathogen after contact with it and infect other persons. According to the Robert Koch Institute, in such a case a person would temporarily carry the virus but would not fall ill. Although transmission is thought to be reduced due to lower and/or less prolonged viral loads in the nasopharynx, scientific evidence is lacking to assess the likelihood of transmission. Therefore, for example, quarantine obligations after contact with persons who have tested positive for Corona virus also apply to vaccinated persons. Furthermore: The vaccination status is not visible to the vaccinated person. If the mask requirement were lifted for vaccinated or recovered persons only, this would be virtually impossible to control in practice.
- Firstly: To reliably protect yourself from contracting severe or life-threatening COVID-19.
- Secondly: Because Corona protection measures cannot be lifted until such a large proportion of the population has been immunized that epidemic spread of the virus can be safely ruled out. If few get vaccinated, there will be no return to how things were before Corona.
- Thirdly: Because widespread vaccination reduces the likelihood of the emergence of further virus mutations. Mutations result from random reproductive errors during virus replication. This happens constantly. However, should one of these virus variants be able to reproduce more successfully - i.e. be more contagious - than others, it will prevail. The fewer people who get sick, the less the virus replicates, the less likely it is that more contagious mutations will emerge.
Vector-based vaccines such as AstraZeneca's COVID-19 vaccine consist of viruses that are harmless to humans and are introduced into the organism. These harmless viruses cannot reproduce in the human organism. However, they have been genetically modified to contain some of the genetic information of the actual virus to be controlled. They therefore serve as carriers (technical term: viral vectors) for a blueprint from which a virus-specific protein is then formed in the human cells. As with the mRNA vaccine, the immune system of the vaccinated person learns to recognize this specific foreign structure and to form antibodies against it. In case of an actual infection with the virus, it is recognized and fought by the immune system.
The genetic information of the virus is degraded by the human organism after a short time. They have no influence on the differently and more complicatedly structured human DNA with the human genetic information.
Vaccine complications are rare, but can never be completely ruled out. If the use of the vaccine causes injury, the pharmaceutical company, among others, may be liable on the basis of various legal principles, depending on the circumstances of the case. Liability regulations may arise under pharmaceutical law, the Product Liability Act (Produkthaftungsgesetz) and the general liability regulations of the German Civil Code (Bürgerliches Gesetzbuch). The Infection Protection Act (Infektionsschutzgesetz, IfSG) section 60(1) sentence 1) also specifies exactly when someone can apply for care under the Federal Care Act (Bundesversorgungsgesetz). This is the case, for example, if someone has suffered damage to their health as a result of a vaccination that was publicly recommended by a competent state authority.
The vaccination is free of charge for you. The CHEMPARK vaccination centers are financed by the participating companies (in alphabetical order): ARLANXEO, Bayer AG, Covestro, the companies of the CURRENTA Group, INEOS in Cologne, LANXESS, Momentive and Saltigo.
The vaccination is carried out either by the company doctors themselves or by MFAs - medical assistants. If necessary, CURRENTA Health Protection will reinforce this with specialist personnel on a selective basis. MFAs also provide care in the observation area. The informative interview or the answering of questions on the medical history form cannot be delegated. In any case, the doctors will take care of that.
Vaccination must be recorded on the vaccination card, but is not stored centrally anywhere. This entry also shows which batch of which preparation was used. The vaccination data - number of persons vaccinated per postal code - are reported anonymously to the responsible health offices or the RKI.
The registration data for the appointment - first name, last name, date of birth and personal or CHEMPARK ID number and vaccination date - are stored as standard. However, every registered user can delete his data himself at any time.
There is a list of persons eligible for vaccination, which has been compiled by the respective CHEMPARK partner according to the criteria of the Coronavirus Vaccination Ordinance (Coronavirus-Impfverordnung). Only the data required for the allocation of vaccination appointments is recorded here: First name, last name, date of birth and personal or CHEMPARK ID number. The list is stored in the tool so that only those eligible for vaccination receive an appointment. The data will be deleted after the vaccination campaign is completed.
It does not record which employees attended an agreed-upon immunization appointment.